or Try an Advanced Search...

    Pharmaceuticals Segment Stocks List

    Symbol Grade Name % Change
    NVO B Novo Nordisk A/S 2.52
    XPH D SPDR S&P Pharmaceuticals ETF 0.33
    PRGO F Perrigo Company -2.86
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Specialty & Generic
    Related Stock Lists: Diabetes Diabetes Care Hormones Pharmaceutical Products Active Pharmaceutical Ingredients Allergy Analgesics Animal Health Anti Diabetic Drugs Biopharmaceutical Cough Dietary Supplement ETF Endocrine System Exchange Traded Fund Feminine Hygiene Gastrointestinal Generic Drug Glucagon Like Peptide 1 Growth Hormone

    Related ETFs - A few ETFs which own one or more of the above listed Pharmaceuticals Segment stocks.

    Symbol Grade Name Weight
    EDEN A iShares MSCI Denmark Capped ETF 23.47
    OZEM B Roundhill GLP-1 & Weight Loss ETF 20.52
    THNR B Amplify Weight Loss Drug & Treatment ETF 14.9
    PPH B Market Vectors Pharmaceutical ETF 10.56
    IGTR A Innovator Gradient Tactical Rotation Strategy ETF 8.71
    View all Pharmaceuticals Segment ETFs...
    Compare ETFs
    Compare EDEN to THNR Compare OZEM to PPH Compare THNR to PPH

        Pharmaceuticals Segment Stocks Recent News

        Date Stock Title
        Jul 5 NVO Study links GLP-1 drugs, metformin to lower risk of certain cancers
        Jul 5 NVO Ozempic Maker Novo Nordisk Reprimanded by UK Regulators for Payment Disclosure Failures
        Jul 5 NVO Novo Nordisk Reprimanded in UK Over Undisclosed Payments; Novartis, Pfizer Found in Breach of Industry Code
        Jul 5 NVO Novo Nordisk reprimanded in UK for failure to disclose payments to healthcare sector
        Jul 5 NVO Is It Too Late to Buy Novo Nordisk Stock?
        Jul 5 NVO Did Vertex Pharmaceuticals Just Invent the Next Ozempic?
        Jul 4 NVO Novo Nordisk: Buy On Dips
        Jul 4 NVO NVO, LLY Slip After Study Links Obesity Drug Use to Vision Loss
        Jul 3 NVO S&P 500, Nasdaq 100 Climb To Record Highs As Data Fosters Rate Cut Optimism Ahead Of Fed Minutes; Gold, Bonds Rally: What's Driving Markets Wednesday?
        Jul 3 NVO Using Obesity Drugs? Potential Vision Loss Disorder Linked To Novo Nordisk's Ozempic And Wegovy, Study Finds
        Jul 3 NVO Novo Nordisk, Eli Lilly Tumble After Study Suggests Weight-Loss Drugs Can Lead To Blindness
        Jul 3 NVO Weight-loss drugs linked to rare vision loss: Harvard study
        Jul 3 NVO Update: Ozempic, Wegovy Linked to Risk of Blinding Eye Condition, Study Shows
        Jul 3 NVO Novo Nordisk’s Ozempic, Wegovy linked to eye disorder in small study
        Jul 3 NVO Ozempic Linked to Rare Cases of Vision Loss in Harvard Study
        Jul 3 NVO Ozempic, Wegovy Linked to Risk of Blinding Eye Condition, Study Shows
        Jul 3 NVO Should You Hold Novo Nordisk A/S (NVO) for the Long Term?
        Jul 2 NVO Novo Nordisk and Eli Lilly Slide as Biden Blasts Weight-Loss Drug Prices
        Jul 2 NVO Biden, Sanders call for obesity drug makers to cut prices
        Jul 2 NVO Fighting words: Lilly and Novo swat back at the Biden/Sanders call for lower GLP-1 prices
        Related Industries: Biotechnology Drug Manufacturers - Specialty & Generic
        Related Stock Lists: Diabetes Diabetes Care Hormones Pharmaceutical Products Active Pharmaceutical Ingredients Allergy Analgesics Animal Health Anti Diabetic Drugs Biopharmaceutical Cough Dietary Supplement ETF Endocrine System Exchange Traded Fund Feminine Hygiene Gastrointestinal Generic Drug Glucagon Like Peptide 1 Growth Hormone
        Pharmaceuticals Segment

        Pharmaceuticals segment is a sector of the healthcare industry that focuses on the research, development, production, and marketing of drugs and other pharmaceutical products. This segment includes companies that manufacture and distribute prescription and over-the-counter drugs, as well as those that provide related services such as contract manufacturing and clinical research.

        Browse All Tags